A pharmaceutical company makes a patented vaccine for a certain disease. It also manufactures a patented drug as treatment for those who contract the disease. Once contracted, the disease cannot be cured, only treated, and treatment is lifelong. A vaccine is a one-time dose priced at $1,000, and if the disease is contracted, the cost of the drug is $100 a month indefinitely. Both have similar costs of production. "Perhaps," an executive at the company says, "we should cut down production of the vaccine. If more people get the disease, that's more people who will use the treatment and more profits for us." What do you think of the executive's idea